Go Back
Cidara Therapeutics, Inc. revenue increases to $25.99 million in quarter ended Mar 31, 2023 from previous quarter
By USInMinutes - May 14, 2023, 03:25 PM ET
Last Updated - Jul 18, 2023, 03:28 PM EDT
Key fundamental financials- profit of $3.21 million
- Revenue of $25.99 million
Current Reporting | Revenue | Net Income | Profit/Loss |
---|---|---|---|
Mar 2023 | $25.99 million | $3.21 million | profit |
Mar 2022 | $7.11 million | $18.28 million | loss |
Cidara Therapeutics, Inc. [CDTX] has reported $3.21 million profit for the fiscal quarter ending Mar 31, 2023.
Revenue for the quarter was $25.99 million with operating income of $2.98 million.
The Sandiego, California (CA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $26.84 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Sponsored
Read More from Quarterly Reports
Read More from USinMinutes
Popular News
Latest News